{
    "clinical_study": {
        "@rank": "136019", 
        "arm_group": [
            {
                "arm_group_label": "Native palm olein", 
                "arm_group_type": "Active Comparator", 
                "description": "75 g native palm olein"
            }, 
            {
                "arm_group_label": "Interesterified palm olein", 
                "arm_group_type": "Experimental", 
                "description": "75 g interesterified palm olein"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether high-fat meals rich in palmitic acid in\n      the sn-2 position decrease lipaemia in men aged 40-70 y with higher than optimal fasting\n      triacylglycerol concentrations."
        }, 
        "brief_title": "Palmitic Acid in the Sn-2 Position of Triacylglycerols and Postprandial Lipemia", 
        "completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Healthy Men", 
            "Raised Fasting Plasma Triacylglycerol Concentrations"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy males\n\n          -  Non-smokers\n\n          -  Aged 40-70 years\n\n          -  Fasting TAG concentrations \u22651.5 mmol/L.\n\n        Exclusion Criteria:\n\n          -  Reported history of CVD (myocardial infarction, angina, venous thrombosis, stroke),\n             impaired fasting glucose/uncontrolled type 2 diabetes (or fasting glucose \u2265 6.1\n             mmol/L), cancer, kidney, liver or bowel disease.\n\n          -  Presence of gastrointestinal disorder or use of drug, which is likely to alter\n             gastrointestinal motility or nutrient absorption.\n\n          -  History of substance abuse or alcoholism (previous weekly alcohol intake >60\n             units/men)\n\n          -  Current self-reported weekly alcohol intake exceeding 28 units\n\n          -  Allergy or intolerance to any component of test meals\n\n          -  Unwilling to restrict consumption of any source of fish oil for the length of the\n             study\n\n          -  Weight change of >3kg in preceding 2 months\n\n          -  Body Mass Index <20 and >35 kg/m2\n\n          -  Fasting blood cholesterol > 7.8 mmol/L\n\n          -  Current cigarette smoker.\n\n          -  Current use of lipid lowering medication"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "11", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01710280", 
            "org_study_id": "IRIS"
        }, 
        "intervention": [
            {
                "arm_group_label": "Native palm olein", 
                "intervention_name": "High-fat meal containing native palm olein", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Interesterified palm olein", 
                "intervention_name": "High-fat meal containing interesterified palm olein", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Lipemia", 
            "Vascular function", 
            "Blood pressure"
        ], 
        "lastchanged_date": "October 18, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "London", 
                    "country": "United Kingdom", 
                    "zip": "SE1 9NH"
                }, 
                "name": "Diabetes & Nutritional Sciences Division, King's College London."
            }
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "other_outcome": {
            "measure": "Incremental AUC for plasma total cholesterol concentrations", 
            "safety_issue": "No", 
            "time_frame": "1-6 h post-meal"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "UK: National Research Ethics Service", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Incremental AUC (change from baseline in overall response) for plasma triacylglycerol concentrations", 
            "safety_issue": "No", 
            "time_frame": "1-6 h post-meal"
        }, 
        "reference": {
            "PMID": "22030225", 
            "citation": "Sanders TA, Filippou A, Berry SE, Baumgartner S, Mensink RP. Palmitic acid in the sn-2 position of triacylglycerols acutely influences postprandial lipid metabolism. Am J Clin Nutr. 2011 Dec;94(6):1433-41. doi: 10.3945/ajcn.111.017459. Epub 2011 Oct 26."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01710280"
        }, 
        "responsible_party": {
            "investigator_affiliation": "King's College London", 
            "investigator_full_name": "Dr Wendy Hall", 
            "investigator_title": "Lecturer in Nutritional Sciences", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Incremental AUC for plasma non-esterified fatty acid concentrations", 
                "safety_issue": "No", 
                "time_frame": "1-6 h post-meal"
            }, 
            {
                "measure": "Changes from baseline in digital volume pulse", 
                "safety_issue": "No", 
                "time_frame": "2,4,5,6 h post-meal"
            }, 
            {
                "measure": "Changes from baseline in blood pressure", 
                "safety_issue": "No", 
                "time_frame": "2,4,5,6 h post-meal"
            }
        ], 
        "source": "King's College London", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "King's College London", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}